Thames Valley Cancer Network

'Update in Myeloid Disorders' & Haematology TSSG Meeting

at:   Oxford Belfry Hotel, Milton Common, Nr Thame, OX9 2JW.

on:   Monday 28th January 2013



  9.00 - 9.25: Registration and tea/coffee

Session 1. Advances in Clinical Management.
Chairman: Dr Tim Littlewood (OUH, Oxford)
  9.25 - 9.30: Welcome and Review of the Day
Prof Paresh Vyas (OUH, Oxford)

  9.30 - 10.00: TOPPS trial - when to give platelets to thrombocytopenic patients
Dr Simon Stanworth (OUH, Oxford)

  10.00 - 10.30: Advances in allografting for Myeloid Disorders
Prof Vanderson Rocha

10.30 - 11.10: SPIRIT 3: the new NCRN phase 3 CML trial
Prof Stephen O'Brien (Professor of Haematology, Newcastle University)

11.10 - 11.30: Coffee break

Session 2. The Future of Myeloid Disorders
Chairman: Dr Adam Mead (OUH, Oxford)
11.30 - 11.40: The use of interferon in the treatment of polycythaemia vera and essential thrombocythaemia
Dr John Willan (OUH, Oxford)

11.40 - 12.00: Purifying leukaemic stem cells in AML: basic and translational studies
Dr Lynn Quek (OUH, Oxford)

12.00 - 12.20: Genetics and biology of MDS Stem Cells
Dr Oni Chowdhury (OUH, Oxford)

12.20 - 12.40: Improving Outcomes for Myeloid Disorders in Thames Valley
Dr Adam Mead, Dr Andy Peniket, Prof Vanderson Rocha, Dr Tim Littlewood and Prof Paresh Vyas (OUH, Oxford)


  2.00Haematology TSSG meeting
Approval has been granted by the Royal College of Pathologists for 3 CPD points.
Please feel free to contact Bridget Watson for further information.

We would like to thank the companies listed below for their sponsorship of this meeting:
(Click on the logo below for a link to the company's web site.)


Return to Home page